Real-time enrollment status for this neoplasm clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 3:54 PM UTC
| NCT Number | NCT06759649 |
| Recruiting Status | Recruiting |
| Condition | Neoplasm |
| Phase | PHASE1 |
| Target Enrollment | 200 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Compugen Ltd |
| Last Updated on CT.gov | August 12, 2026 (Aug 12, 2026) |
As of October 13, 2026: Clinical trial NCT06759649 is currently recruiting participants. This phase1 study for neoplasm is actively seeking new participants at 7 locations across the United States. The study is sponsored by Compugen Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06759649 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06759649 was last updated Aug 12, 2026 (August 12, 2026). HelloStudys verifies this status automatically.